About BroadenBio
Company Profile
BroadenBio Co., Ltd. ("BroadenBio"), co-founded by senior experts on drug discovery and development returning to China from overseas big pharmaceutical companies, is a growing biotechnology company in clinical-stage focusing on oncology and autoimmune diseases. Since its foundation, BroadenBio has received the investment of many well-known institutions, and has established a unique immunology platform and a molecular conjugation technology platform for drug discovery. Based on the concept of “Immuno-Oncology 2.0” (immuno-oncology + targeted therapy), BroadenBio has started a number of pipelines and aims at developing First-in-Class (FIC) or Best-in-Class (BIC) new drugs fulfilling the unmet clinical needs. At the same time, BroadenBio has been actively exploring domestic and international collaboration, in the vision of benefitting human health via immunotherapy.
address：
A1-602, 88 Kechuang 6th Street, BDA, Beijing 100176
phone：
Copyright ©2019 BroadenBio